Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
Carbapenems are commonly used to treat infections caused by multidrug-resistant (MDR) bacteria. Unfortunately, carbapenem resistance is increasingly reported in many gram-negative bacteria, especially Acinetobacter baumannii. Diazabicyclooctane (DBO) β-lactamase inhibitors, such as avibactam (AVI),...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2022-07-01
|
| Серія: | Frontiers in Cellular and Infection Microbiology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.918868/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|